Omeros Corp (OMER) navigates financial hurdles with a promising Novo Nordisk deal and prepares for a pivotal drug launch.

Blaize Holdings Inc (BZAI) reports a 499% revenue increase and secures key investments, while navigating decreased margins and competitive pressures.